These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 30153886

  • 1. Meta-analysis of randomized controlled trials for the efficacy and safety of anti-interleukin-13 therapy with lebrikizumab in patients with uncontrolled asthma.
    Liu Y, Zhang S, Chen R, Wei J, Guan G, Zhou M, Dong N, Cao Y.
    Allergy Asthma Proc; 2018 Sep 01; 39(5):332-337. PubMed ID: 30153886
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials.
    Hanania NA, Korenblat P, Chapman KR, Bateman ED, Kopecky P, Paggiaro P, Yokoyama A, Olsson J, Gray S, Holweg CT, Eisner M, Asare C, Fischer SK, Peng K, Putnam WS, Matthews JG.
    Lancet Respir Med; 2016 Oct 01; 4(10):781-796. PubMed ID: 27616196
    [Abstract] [Full Text] [Related]

  • 3. Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids.
    Noonan M, Korenblat P, Mosesova S, Scheerens H, Arron JR, Zheng Y, Putnam WS, Parsey MV, Bohen SP, Matthews JG.
    J Allergy Clin Immunol; 2013 Sep 01; 132(3):567-574.e12. PubMed ID: 23726041
    [Abstract] [Full Text] [Related]

  • 4. Lebrikizumab treatment in adults with asthma.
    Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, Mosesova S, Eisner MD, Bohen SP, Matthews JG.
    N Engl J Med; 2011 Sep 22; 365(12):1088-98. PubMed ID: 21812663
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of anti-interleukin-5 therapies in patients with severe asthma: global and indirect meta-analyses of randomized placebo-controlled trials.
    Cabon Y, Molinari N, Marin G, Vachier I, Gamez AS, Chanez P, Bourdin A.
    Clin Exp Allergy; 2017 Jan 22; 47(1):129-138. PubMed ID: 27859832
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of dupilumab for the treatment of uncontrolled asthma: a meta-analysis of randomized clinical trials.
    Xiong XF, Zhu M, Wu HX, Fan LL, Cheng DY.
    Respir Res; 2019 May 31; 20(1):108. PubMed ID: 31151443
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lebrikizumab for the treatment of asthma.
    Antoniu SA.
    Expert Opin Investig Drugs; 2016 Oct 31; 25(10):1239-49. PubMed ID: 27554950
    [Abstract] [Full Text] [Related]

  • 16. Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.
    Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, Busse WW, Ford L, Sher L, FitzGerald JM, Katelaris C, Tohda Y, Zhang B, Staudinger H, Pirozzi G, Amin N, Ruddy M, Akinlade B, Khan A, Chao J, Martincova R, Graham NMH, Hamilton JD, Swanson BN, Stahl N, Yancopoulos GD, Teper A.
    N Engl J Med; 2018 Jun 28; 378(26):2486-2496. PubMed ID: 29782217
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of anti-interleukin-5 therapy in patients with asthma: A pairwise and Bayesian network meta-analysis.
    He LL, Zhang L, Jiang L, Xu F, Fei DS.
    Int Immunopharmacol; 2018 Nov 28; 64():223-231. PubMed ID: 30199847
    [Abstract] [Full Text] [Related]

  • 18. The Safety and Efficacy of Anti-IL-13 Treatment with Tralokinumab (CAT-354) in Moderate to Severe Asthma: A Systematic Review and Meta-Analysis.
    Zhang Y, Cheng J, Li Y, He R, Pan P, Su X, Hu C.
    J Allergy Clin Immunol Pract; 2019 Nov 28; 7(8):2661-2671.e3. PubMed ID: 31152798
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.